Clinical and neuroimaging heterogeneity of dementia with Lewy bodies
Objective: To study clinical and neuroimaging features of dementia with Lewy bodies (DLB) for optimal management and prognosis of the disease. Background: Appropriate diagnosis of DLB…Visuospatial dysfunction correlates with severity of postural instability/gait disturbance symptoms in parkinson’s disease
Objective: Investigate the relationship between global and specific cognitive functions and PIGD symptoms in Parkinson’s disease Background: It is well known that cognition and motor…Vascular risk factors, WMLs and the risk of cognitive impairment in Parkinson disease: A longitudinal study from the Parkinson’s Disease Cognitive Impairment Study (PaCoS) cohort
Objective: To identify modifiable vascular risk factors (VRFs) associated with cognitive decline in early PD. Background: The importance of the early identification of modifiable risk…Identifying subtypes of Mild Cognitive Impairment in Parkinson’s disease using cluster analysis
Objective: To identify cognitive phenotypes within Parkinson’s disease (PD) and compare them to the current Movement Disorder Society (MDS) diagnostic standards for Mild Cognitive Impairment…Heart Rate Variability and Cognitive Impairment in Parkinson’s Disease
Objective: To evaluate the association between the heart rate variability (HRV) and cognitive impairment in PD patients. Background: Emerging evidence suggests an association between cognitive…A videographic tool for quantitative assessment of the Glabellar Reflex
Objective: We developed a videographic tool to quantitatively assess the Glabellar Reflex (GR) in healthy patients for further analysis in Parkinson (PD) patients. Background: The…Neural plasticity based on the change of the glutamate receptors: Repetition of electrical stimulation for the reduction of Parkinsonian symptoms
Objective: This study investigated the fundamental mechanism how the repeated electrical stimulation (ES) affects the reduction of parkinsonian symptoms. Background: The reduced parkinsonian symptoms by…The role of lipid metabolism in mouse models of Parkinson’s disease
Objective: To investigate the role of lipid metabolism and the effect of blocking carnitine palmitoyl-transferase 1 (CPT1) in toxic and genetically mouse models of Parkinson’s…Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland
Objective: The objective of the study was to determine whether PD prevalence exhibit any spatial dependence in order to get hypothesis on PD risk or…Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
Objective: To find out phenotypes of movement disorders related to COPD, and also associated factors. Background: Movement disorders in systemic diseases exactly are common in…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.